Scavenger protein receptor aids the transport of lipoproteins
Lipoproteins are spherical molecules made up of fat and proteins that play a crucial role in transporting lipids, such as cholesterol and triglycerides, from the liver to other tissues in the body. Anton Potapenko of the University of Zurich, and a team in Switzerland recently published a study in the Journal of Lipid Research detailing structural characteristics of the scavenger receptor B1, or SCARB1, a protein that mediates lipid exchange between many cell types and facilitates uptake of high density lipoproteins, or HDL, and low density lipoproteins, or LDL, in some cell types. The gene encoding SCARB1 produces two major splice variants that share structural similarities but differ in their carboxy-terminal domains. Researchers wanted to understand if these splice variants play different roles in the cellular uptake of LDL and HDL by endothelial cells.
The researchers examined cultured endothelial cells to understand how expression of the two SCARB1 variants affected the binding, uptake and trafficking of lipoproteins. They found that variants 1 and 2 localized to the cell surface, and endosomes and lysosomes, respectively. Overexpression of variant 1 increased both HDL and LDL binding and uptake. However, overexpression of variant 2 also increased the uptake of either lipoprotein, but not via surface binding. Therefore, the researchers concluded that variant 2 facilitates lipoprotein uptake indirectly by regulatory and indirect mechanisms.
The study suggests that the two major splice variants of SCARB1 facilitate transendothelial transport of HDL and LDL by different mechanisms, either dependent or independent of the adapter proteins. Because of the limitations of overexpression, it will be important to examine how eliminating each SCARB1 splice variant affects cellular lipid metabolism and lipoprotein trafficking.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.